| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Molecular and Cellular Pharmacology University of Miami School of Medicine Miami, Florida 33101
The androgen receptor (AR) gene is transcriptionally regulated by AR (autoregulation); however, the androgen response elements (AREs) required for this process have not been found in the AR promoter or in the 5'-flanking region. We previously showed that the AR cDNA contains AREs involved in AR mRNA autoregulation and that auto(up)regulation is reproduced in PC3 cells (a human prostate cancer cell line) expressing the human AR cDNA driven by a heterologous promoter. A 350-bp fragment of the AR cDNA contains the requisite AREs (ARE-1 and ARE-2) and, when linked upstream of a reporter gene, confers androgen inducibility in a cell-specific manner. Here we report that, although an AR cDNA harboring silent mutations of ARE-1 and ARE-2 produces a transcriptionally active AR, AR mRNA encoded by this mutant cDNA is not up-regulated in androgen-treated PC3 cells. Thus, ARE-1 and ARE-2 are essential for androgen-mediated up-regulation of AR mRNA in this model. Since ARE-1 and ARE-2 are located on separate exons (exons D and E) in the AR gene, we evaluated these AREs in their native context, a 6.5-kb AR genomic fragment. Androgen regulated the 6.5-kb AR genomic fragment and the 350-bp region of the AR cDNA at comparable levels, suggesting that sequences in exons D and E are likely to be involved in androgen-mediated up-regulation of the native AR gene. Furthermore, androgen regulated both responsive regions in U2OS cells, a human osteoblastic cell line that exhibits androgen-mediated up-regulation of native AR mRNA. DNAse I footprinting of the 350-bp region with recombinant AR (DNA- and ligand-binding domains) suggested the presence of additional AREs. Gel shift analyses and mutational studies showed that maximal androgen regulation and AR binding were dependent on the integrity of four AREs (ARE-1, ARE-1A, IVSARE, and ARE-2). While the presence of multiple, nonconsensus AREs is common among other androgen-regulated enhancers, the androgen-responsive region of the AR gene is unique because it contains exonic AREs. DNA binding studies with nuclear extracts were performed to determine whether non-AR transcription factors contribute to androgen regulation of the 350-bp region. These studies, in conjunction with mutational analysis and reporter gene assays with dominant negative Myc and Max expression vectors, showed that Myc and Max interaction with a Myc consensus site is required for androgen regulation of the 350-bp fragment. These results represent a novel interaction between AR and the Myc family of proteins and support a model of androgenic control of AR mRNA via AR and Myc family interaction with a unique internal androgen-responsive region harboring multiple exonic regulatory sequences.
This article has been cited by other articles:
![]() |
S. Ko, L. Shi, S. Kim, C. S. Song, and B. Chatterjee Interplay of Nuclear Factor-{kappa}B and B-myb in the Negative Regulation of Androgen Receptor Expression by Tumor Necrosis Factor {alpha} Mol. Endocrinol., February 1, 2008; 22(2): 273 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ye, S. J. Han, S. Y. Tsai, F. J. DeMayo, J. Xu, M.-J. Tsai, and B. W. O'Malley Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice PNAS, July 5, 2005; 102(27): 9487 - 9492. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H Walker and J. Cheng FSH and testosterone signaling in Sertoli cells Reproduction, July 1, 2005; 130(1): 15 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sandelin and W. W. Wasserman Prediction of Nuclear Hormone Receptor Response Elements Mol. Endocrinol., March 1, 2005; 19(3): 595 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. Chiu, F.-J. Hsieh, S.-W. Chen, C.-L. Chen, H.-F. Shu, and H. Li Clinicopathologic Correlation of Up-regulated Genes Identified Using cDNA Microarray and Real-time Reverse Transcription-PCR in Human Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 437 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Edwards, N. S. Krishna, C. J. Witton, and J. M. S. Bartlett Gene Amplifications Associated with the Development of Hormone-Resistant Prostate Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5271 - 5281. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Iversen, V. Arora, A. Acker, D. H. Mason, and G. R. Devi Efficacy of Antisense Morpholino Oligomer Targeted to c-myc in Prostate Cancer Xenograft Murine Model and a Phase I Safety Study in Humans Clin. Cancer Res., July 1, 2003; 9(7): 2510 - 2519. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Mitchell and N. H. Ing Estradiol Stabilizes Estrogen Receptor Messenger Ribonucleic Acid in Sheep Endometrium via Discrete Sequence Elements in Its 3'-Untranslated Region Mol. Endocrinol., April 1, 2003; 17(4): 562 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Cheng, C. H. Cheung, and W. M. Lee Mouse Testin: Complementary DNA Cloning, Genomic Organization, and Characterization of Its Proximal Promoter Region Biol Reprod, April 1, 2003; 68(4): 1376 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wu and D. M. Terrian Regulation of Caveolin-1 Expression and Secretion by a Protein Kinase Cepsilon Signaling Pathway in Human Prostate Cancer Cells J. Biol. Chem., October 18, 2002; 277(43): 40449 - 40455. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Martinez and M. Danielsen Loss of Androgen Receptor Transcriptional Activity at the G1/S Transition J. Biol. Chem., August 9, 2002; 277(33): 29719 - 29729. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Gelmann Molecular Biology of the Androgen Receptor J. Clin. Oncol., July 1, 2002; 20(13): 3001 - 3015. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohsako, Y. Miyabara, M. Sakaue, R. Ishimura, M. Kakeyama, H. Izumi, J. Yonemoto, and C. Tohyama Developmental Stage-Specific Effects of Perinatal 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure on Reproductive Organs of Male Rat Offspring Toxicol. Sci., April 1, 2002; 66(2): 283 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ostrer Genome and Hormones: Gender Differences in Physiology: Invited Review: Sex-based differences in gene expression J Appl Physiol, November 1, 2001; 91(5): 2384 - 2388. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bieche, B. Parfait, S. Tozlu, R. Lidereau, and M. Vidaud Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene Carcinogenesis, September 1, 2001; 22(9): 1521 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-L. Lin, M. C. Whitney, Z. Yao, and E. T. Keller Interleukin-6 Induces Androgen Responsiveness in Prostate Cancer Cells through Up-Regulation of Androgen Receptor Expression Clin. Cancer Res., June 1, 2001; 7(6): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grad, L. S. Lyons, D. M. Robins, and K. L. Burnstein The Androgen Receptor (AR) Amino-Terminus Imposes Androgen-Specific Regulation of AR Gene Expression via an Exonic Enhancer Endocrinology, March 1, 2001; 142(3): 1107 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohsako, Y. Miyabara, N. Nishimura, S. Kurosawa, M. Sakaue, R. Ishimura, M. Sato, K. Takeda, Y. Aoki, H. Sone, et al. Maternal Exposure to a Low Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Suppressed the Development of Reproductive Organs of Male Rats: Dose-Dependent Increase of mRNA Levels of 5{{alpha}}-Reductase Type 2 in Contrast to Decrease of Androgen Receptor in the Pubertal Ventral Prostate Toxicol. Sci., March 1, 2001; 60(1): 132 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Reid, S. C. Hendy, J. Saito, P. Sorensen, and C. C. Nelson Two Classes of Androgen Receptor Elements Mediate Cooperativity through Allosteric Interactions J. Biol. Chem., January 19, 2001; 276(4): 2943 - 2952. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Urnov and A. P. Wolffe An Array of Positioned Nucleosomes Potentiates Thyroid Hormone Receptor Action in Vivo J. Biol. Chem., June 1, 2001; 276(23): 19753 - 19761. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |